Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes

Reducing severe cutaneous adverse and type B adverse drug reactions using pre‐stored human leukocyte antigen genotypes

Abstract Background Several type B adverse drug reactions (ADRs), especially severe cutaneous adverse reactions (SCARs), are associated with particular human leukocyte antigen (HLA) genotypes. However, pre‐stored HLA information obtained from other clinical workups has not been used to prevent ADRs....

Full description

Bibliographic Details
Main Authors: Kye Hwa Lee, Dong Yoon Kang, Hyun Hwa Kim, Yi Jun Kim, Hyo Jung Kim, Ju Han Kim, Eun Young Song, James Yun, Hye‐Ryun Kang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Clinical and Translational Allergy
Subjects:
humanes leukozytenantigen
pharmakogenomik
präventive genotypisierung
uberempfindlichkeit
unerwünschte arzneimittelwirkung
Online Access:https://doi.org/10.1002/clt2.12098

Internet

https://doi.org/10.1002/clt2.12098

Similar Items